SHH-N non-canonically sustains androgen receptor activity in androgen-independent prostate cancer cells
Abstract Prostate cancer is the second most frequent cancer diagnosed in men worldwide. Localized disease can be successfully treated, but advanced cases are more problematic. After initial effectiveness of androgen deprivation therapy, resistance quickly occurs. Therefore, we aimed to investigate t...
Guardado en:
Autores principales: | Diana Trnski, Maja Sabol, Sanja Tomić, Ivan Štefanac, Milanka Mrčela, Vesna Musani, Nikolina Rinčić, Matea Kurtović, Tina Petrić, Sonja Levanat, Petar Ozretić |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a35aa281398c4fa6bbbb5775d4883d32 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Androgens, Endometriosis and Pain
por: Susan F. Evans, et al.
Publicado: (2021) -
Androgen-induced cell migration: role of androgen receptor/filamin A association.
por: Gabriella Castoria, et al.
Publicado: (2011) -
Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.
por: Dominick G A Burton, et al.
Publicado: (2013) -
The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients
por: Ranakishor Pelluri, M.Pharm, PDCR, Ph.D, et al.
Publicado: (2021) -
Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy
por: Hao Geng, et al.
Publicado: (2018)